title: Reply to Carev et al: "Useful supplement to the best practice of using levosimendan in cardiac surgery patients: 2.5 mg intravenous bolus for cardiopulmonary resuscitation during perioperative cardiac arrest".
authors.affiliation: Medical University of Graz, Graz, Austria.
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Toller
authors.forename: Fabio
authors.initials: F
authors.lastname: Guarracino
authors.forename: Giovanni
authors.initials: G
authors.lastname: Landoni
mesh_terms: D006348:Cardiac Surgical Procedures / Q000379:methods*; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D011724:Pyridazines / Q000627:therapeutic use*
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines